查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1428154

2024 年全球兽用生技药品市场报告

Veterinary Biologics Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

兽用生技药品的市场规模预计在未来几年将显着成长。预计到 2028 年将以 7.6% 的复合年增长率 (CAGR) 增长至 171.1 亿美元。预测期内的预期增长是由多种因素造成的，包括新兴感染疾病的增加、气候变迁影响导致的疾病模式的变化、精准畜牧业的进步、综合「同一个健康」方法的采用以及日益增长的趋势感染疾病，可能与因素有关。宠物所有权。这段时期预计的主要趋势包括教育和培训计划、绿色和永续生物製药的开发、数位健康记录的整合、伴同性生物製药的扩散以及客製化标靶治疗的扩展，其中包括普及等。

动物疾病盛行率的激增预计将推动动物生技药品市场的成长。动物疾病包括影响不同动物物种的多种疾病。这些疾病的增加凸显了对先进诊断和治疗解决方案的需求，而采用免疫学方法来解决和管理动物疾病的兽医生技药品正在满足这一需求。截至2022年10月，欧洲疾病预防控制中心已通报家禽爆发2,467起禽流感疫情，影响4,800万隻禽类，另外在圈养禽类中观察到187例病例。在此背景下，世界卫生组织于2022年7月宣布，狂犬病每年在150多个国家夺走59,000人的生命，其中大部分病例集中在非洲和亚洲。动物疾病的激增是推动动物生技药品市场的关键因素。

收养宠物的趋势预计将极大促进动物生技药品市场的成长。宠物收养涉及为家养动物提供一个有爱心、负责任且永久的家，通常来自收容所或救援组织。兽用生技药品有助于预防宠物感染疾病、提供免疫力、控制通用感染疾病、延长寿命和生活品质、降低兽医费用、改善宠物生殖健康、提供更有针对性的保护，在提供针对性和客製化治疗方面发挥关键作用选项。根据美国宠物产品协会 2023 年 10 月报告的资料，66% 的美国家庭（总合为 8,690 万）拥有宠物，高于 2022 年的 62%。宠物收养人数的迅速增加是宠物拥有量扩大的主要动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球兽用生技药品市场的驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023年全球兽用生技药品市场规模、表现与成长
  • 全球动物生技药品市场规模及成长预测，2023-2028、2033

第六章市场区隔

  • 全球兽用生技药品市场，依产品、绩效及预测细分，2018-2023、2023-2028、2033
  • 疫苗
  • 诊断套件
  • 免疫调节剂
  • 抗血清和抗体
  • 其他的
  • 全球兽用生技药品市场，依疾病、表现及预测细分，2018-2023、2023-2028、2033
  • 蓝舌头
  • 手足口病
  • 布氏桿菌症和结核病
  • 其他的
  • 全球兽用生技药品市场，依通路细分、绩效及预测，2018-2023、2023-2028、2033
  • 动物医院
  • 动物诊所
  • 其他的
  • 全球兽用生技药品市场，依应用、绩效及预测细分，2018-2023、2023-2028、2033
  • 生产动物
  • 伴同性动物

第 7 章 区域与国家分析

  • 全球兽用生技药品市场，依地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球兽用生技药品市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 兽用生技药品市场竞争形势
  • 兽用生技药品市场的公司概况
    • Bayer AG
    • Eli Lilly &Company
    • Evonik Industries AG
    • Zoetis Inc.
    • VCA Inc.

第31章 其他大型创新公司

  • Merck Animal Health Inc.
  • Boehringer Ingelheim Animal Health Inc.
  • Elanco Animal Health
  • IDEXX Laboratories Inc.
  • Nutreco NV
  • Virbac SA
  • Hologic Inc.
  • Phibro Animal Health Corporation
  • Vetoquinol
  • Valneva
  • Abaxis Inc.
  • Bimeda Biologicals
  • Ceva Sante Animale SA
  • Heska Corporation
  • Heska Corporation

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与潜力分析

第36章附录

简介目录
Product Code: r13998

Veterinary biologics encompass biological products obtained from living organisms such as viruses, bacteria, or other microorganisms. These specialized products in veterinary medicine serve to prevent, diagnose, or treat diseases in animals.

Key products falling under veterinary biologics include vaccines, diagnostic kits, immunomodulators, antiserums, antibodies, and related items. Vaccines, for instance, are formulated to trigger the immune system's response and offer protection against specific animal diseases. They address various ailments such as bluetongue, foot and mouth disease, brucellosis, tuberculosis, and others. These products are distributed through multiple channels, including veterinary hospitals and clinics, for diverse applications involving both production and companion animals.

The veterinary biologics market research report is one of a series of new reports from The Business Research Company that provides veterinary biologics market statistics, including veterinary biologics industry global market size, regional shares, competitors with a veterinary biologics market share, detailed veterinary biologics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biologics industry. This veterinary biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary biologics market size has grown strongly in recent years. It will grow from $11.77 billion in 2023 to $12.78 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth observed in the historic period can be linked to several factors. These include occurrences of animal disease outbreaks, supportive regulatory frameworks and standards, an increasing emphasis on food safety, the globalization of trade, and the substantial economic importance placed on livestock.

The veterinary biologics market size is expected to see strong growth in the next few years. It will grow to $17.11 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The anticipated growth in the forecast period can be tied to several factors, including the rise of emerging infectious diseases, changing disease patterns influenced by climate change, advancements in precision livestock farming, the adoption of a holistic One Health approach, and the increasing trend of pet ownership. Key trends expected in this period encompass education and training programs, the development of eco-friendly and sustainable biologics, integration of digital health records, a surge in companion animal biologics, and the proliferation of customized and targeted therapies.

The upsurge in the prevalence of animal diseases is anticipated to be a driving force behind the growth of the veterinary biologics market. Animal diseases encompass a range of illnesses affecting diverse animal species. The escalation in these diseases underscores the need for advanced diagnostic and treatment solutions, a demand met by veterinary biologics that employ immunological methods to address and manage animal diseases. As of October 2022, the European Center for Disease Prevention and Control reported 2,467 outbreaks of avian influenza in poultry, impacting 48 million birds, with an additional 187 cases observed in captive birds. In a related context, the World Health Organization disclosed in July 2022 that rabies claims the lives of 59,000 people annually across over 150 countries, with a predominant 95% of cases concentrated in Africa and Asia. This surge in animal diseases is a pivotal factor propelling the veterinary biologics market.

The increasing trend of pet adoption is poised to contribute significantly to the growth of the veterinary biologics market. Pet adoption involves assuming responsibility for a domesticated animal, often from shelters or rescue organizations, to provide a permanent and caring home. Veterinary biologics play a crucial role in preventing infectious diseases in pets, offering immunity, controlling zoonotic diseases, enhancing lifespan and quality of life, reducing veterinary healthcare costs, improving reproductive health in pets, and providing more targeted and customized treatment options. Data from October 2023, as reported by the American Pet Products Association, reveals that 66% of U.S. households, totaling 86.9 million, own a pet-an increase from 62% in 2022. This surge in pet adoption is a significant driver behind the expanding veterinary biologics market.

The trend of developing innovative biologics is gaining momentum in the veterinary biologics market, with major companies spearheading efforts in this direction. In March 2021, Elanco Animal Health Incorporated, a prominent U.S.-based veterinary pharmaceutical company, introduced Elura (capromorelin oral solution) to address weight loss in cats afflicted with chronic kidney diseases (CKD). Notably, Elura represents the inaugural ghrelin receptor agonist sanctioned by the U.S. Food and Drug Administration (FDA), utilizing a novel mechanism to combat weight loss in cats with CKD. This oral solution, characterized by a palatable taste and a minimal dosage, serves as a long-term treatment option introduced at the time of diagnosis, supporting cat owners in managing their animals through this ailment.

Companies at the forefront of the veterinary biologics market are also channeling their efforts into the creation of innovative products, such as injections designed to control pain associated with osteoarthritis (OA) in dogs. These injections target canine nerve growth factors, providing an effective means to alleviate the pain that dogs experience due to osteoarthritis. Zoetis Inc., a distinguished U.S.-based animal health company, secured approval from the U.S. Food and Drug Administration (FDA) for Librela (bedinvetmab injection) in May 2023. Positioned as the first and only monthly anti-NGF monoclonal antibody medication for canine OA pain, Librela stands out as a safe and efficacious solution for managing long-term OA pain symptoms in dogs. This approval underscores Librela's role in enhancing the mobility and overall well-being of canines grappling with osteoarthritis, contributing to an improved quality of life for these animals.

In August 2021, Elanco Animal Health Incorporated, a US-based animal health company, completed the acquisition of Kindred Biosciences for approximately $444 million. Through this strategic acquisition, Elanco aimed to strengthen its position in the dermatology market within the veterinary medicine sector. This acquisition enabled Elanco to not only cater more effectively to its current customer base but also expand its reach by attracting new clients. Kindred Biosciences, the acquired company, specializes in the development of biologics and advanced technologies for veterinary medicine.

Major companies operating in the veterinary biologics market report are Bayer AG, Eli Lilly & Company,Evonik Industries AG, Zoetis Inc., VCA Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Nutreco N.V., Virbac SA, Hologic Inc., Phibro Animal Health Corporation, Vetoquinol, Valneva, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Ambrx Biopharma Inc., Adamis Pharmaceuticals Corporation, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd.,FidoCure, Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics

North America was the largest region in the veterinary biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The veterinary biologics market consists of sales of transplant tissues, recombinant proteins, and stem cells. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Vaccines; Diagnostic Kits; Immunomodulators; Antiserums And Antibodies; Other Products
  • 2) By Disease Type: Bluetongue; Foot And Mouth Disease; Brucellosis And Tuberculosis; Other Diseases
  • 3) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Other Distribution Channels
  • 4) By Application: Production Animal; Companion Animal
  • Companies Mentioned: Bayer AG; Eli Lilly & Company;Evonik Industries AG; Zoetis Inc.; VCA Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Biologics Market Characteristics

3. Veterinary Biologics Market Trends And Strategies

4. Veterinary Biologics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Veterinary Biologics Market Size and Growth

  • 5.1. Global Veterinary Biologics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Veterinary Biologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Veterinary Biologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Veterinary Biologics Market Segmentation

  • 6.1. Global Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Vaccines
  • Diagnostic Kits
  • Immunomodulators
  • Antiserums And Antibodies
  • Other Products
  • 6.2. Global Veterinary Biologics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bluetongue
  • Foot And Mouth Disease
  • Brucellosis And Tuberculosis
  • Other Diseases
  • 6.3. Global Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Veterinary Hospitals
  • Veterinary Clinics
  • Other Distribution Channels
  • 6.4. Global Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Production Animal
  • Companion Animal

7. Veterinary Biologics Market Regional And Country Analysis

  • 7.1. Global Veterinary Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Veterinary Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Veterinary Biologics Market

  • 8.1. Asia-Pacific Veterinary Biologics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Veterinary Biologics Market

  • 9.1. China Veterinary Biologics Market Overview
  • 9.2. China Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Veterinary Biologics Market

  • 10.1. India Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Veterinary Biologics Market

  • 11.1. Japan Veterinary Biologics Market Overview
  • 11.2. Japan Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Veterinary Biologics Market

  • 12.1. Australia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Veterinary Biologics Market

  • 13.1. Indonesia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Veterinary Biologics Market

  • 14.1. South Korea Veterinary Biologics Market Overview
  • 14.2. South Korea Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Veterinary Biologics Market

  • 15.1. Western Europe Veterinary Biologics Market Overview
  • 15.2. Western Europe Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Veterinary Biologics Market

  • 16.1. UK Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Veterinary Biologics Market

  • 17.1. Germany Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Veterinary Biologics Market

  • 18.1. France Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Veterinary Biologics Market

  • 19.1. Italy Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Veterinary Biologics Market

  • 20.1. Spain Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Veterinary Biologics Market

  • 21.1. Eastern Europe Veterinary Biologics Market Overview
  • 21.2. Eastern Europe Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Veterinary Biologics Market

  • 22.1. Russia Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Veterinary Biologics Market

  • 23.1. North America Veterinary Biologics Market Overview
  • 23.2. North America Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Veterinary Biologics Market

  • 24.1. USA Veterinary Biologics Market Overview
  • 24.2. USA Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Veterinary Biologics Market

  • 25.1. Canada Veterinary Biologics Market Overview
  • 25.2. Canada Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Veterinary Biologics Market

  • 26.1. South America Veterinary Biologics Market Overview
  • 26.2. South America Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Veterinary Biologics Market

  • 27.1. Brazil Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Veterinary Biologics Market

  • 28.1. Middle East Veterinary Biologics Market Overview
  • 28.2. Middle East Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Veterinary Biologics Market

  • 29.1. Africa Veterinary Biologics Market Overview
  • 29.2. Africa Veterinary Biologics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Veterinary Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Veterinary Biologics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Veterinary Biologics Market Competitive Landscape And Company Profiles

  • 30.1. Veterinary Biologics Market Competitive Landscape
  • 30.2. Veterinary Biologics Market Company Profiles
    • 30.2.1. Bayer AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Eli Lilly & Company
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Evonik Industries AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Zoetis Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. VCA Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Veterinary Biologics Market Other Major And Innovative Companies

  • 31.1. Merck Animal Health Inc.
  • 31.2. Boehringer Ingelheim Animal Health Inc.
  • 31.3. Elanco Animal Health
  • 31.4. IDEXX Laboratories Inc.
  • 31.5. Nutreco N.V.
  • 31.6. Virbac SA
  • 31.7. Hologic Inc.
  • 31.8. Phibro Animal Health Corporation
  • 31.9. Vetoquinol
  • 31.10. Valneva
  • 31.11. Abaxis Inc.
  • 31.12. Bimeda Biologicals
  • 31.13. Ceva Sante Animale S.A.
  • 31.14. Heska Corporation
  • 31.15. Heska Corporation

32. Global Veterinary Biologics Market Competitive Benchmarking

33. Global Veterinary Biologics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Veterinary Biologics Market

35. Veterinary Biologics Market Future Outlook and Potential Analysis

  • 35.1 Veterinary Biologics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Veterinary Biologics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Veterinary Biologics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer